Search Results - "amyloid"
Suggested Topics within your search.
Suggested Topics within your search.
- Nervous system
- Degeneration 16
- Neurodegenerative Diseases 16
- Alzheimer Disease 11
- Alzheimer's disease 9
- pathology 9
- Amyloid 8
- Diagnosis 7
- Frontotemporal Dementia 6
- Amyloid beta-Peptides 5
- Brain 5
- Neurons 5
- Genetic aspects 4
- Parkinson Disease 4
- genetics 4
- Amyloid beta-protein 3
- Chemotherapy 3
- HSP40 Heat-Shock Proteins 3
- Molecular chaperones 3
- Pathogenesis 3
- Protein Conformation 3
- Protein Folding 3
- Protein folding 3
- drug therapy 3
- etiology 3
- metabolism 3
- physiopathology 3
- Amyloidogenic Proteins 2
- Atrophy 2
- Biochemical markers 2
-
1
Targeting Aß oligomers a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease /
Published 2014Table of Contents: “…Contents: The oligomer cascade hypothesis for Alzheimer's Disease -- Why the oligomer hypothesis has largely supplanted the amyloid cascade hypothesis -- The role of AβOs in memory failure and the major facets of AD neuropathology -- Mechanisms by which AβOs instigate neurotoxicity -- Why AβOs accumulate in the first place -- How AβOs offer superb targets for novel AD diagnostics and disease-modifying therapeutics -- Beside its direct link to Alzheimer's disease, the discovery of toxic Aβ oligomers has provided a novel structural archetype for toxins germane to more than two dozen diseases of protein mis-folding, including Diabetes, Parkinson's, and prion diseases.…”
Get full text
Series
Electronic Video -
2
Targeting Aß oligomers a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease /
Published 2014Table of Contents: “…Contents: The oligomer cascade hypothesis for Alzheimer's Disease -- Why the oligomer hypothesis has largely supplanted the amyloid cascade hypothesis -- The role of AβOs in memory failure and the major facets of AD neuropathology -- Mechanisms by which AβOs instigate neurotoxicity -- Why AβOs accumulate in the first place -- How AβOs offer superb targets for novel AD diagnostics and disease-modifying therapeutics -- Beside its direct link to Alzheimer's disease, the discovery of toxic Aβ oligomers has provided a novel structural archetype for toxins germane to more than two dozen diseases of protein mis-folding, including Diabetes, Parkinson's, and prion diseases.…”
Get full text
Series
Electronic Video -
3
Targeting Aß oligomers a molecular basis for the cause, diagnosis, and treatment of Alzheimer's disease /
Published 2014Table of Contents: “…Contents: The oligomer cascade hypothesis for Alzheimer's Disease -- Why the oligomer hypothesis has largely supplanted the amyloid cascade hypothesis -- The role of AβOs in memory failure and the major facets of AD neuropathology -- Mechanisms by which AβOs instigate neurotoxicity -- Why AβOs accumulate in the first place -- How AβOs offer superb targets for novel AD diagnostics and disease-modifying therapeutics -- Beside its direct link to Alzheimer's disease, the discovery of toxic Aβ oligomers has provided a novel structural archetype for toxins germane to more than two dozen diseases of protein mis-folding, including Diabetes, Parkinson's, and prion diseases.…”
Get full text
Series
Electronic Video -
4
Update on fluid biomarkers for neurodegenerative diseases
Published 2022Table of Contents: “…Contents: Fluid biomarker candidates for neurodegenerative disease -- Amyloid pathology -- CSF and plasma/serum NfL -- CSF Aβ42 in Alzheimer's disease and neuroinflammatory diseases -- Tau pathology in Alzheimer's disease -- Neurodegeneration -- CSF and plasma NfL as biomarkers for disease progression -- Drug treatment and NfL levels.…”
Get full text
Series (Biomarkers)
Series (Drug discovery and development in the neurosciences)
Series (Genetic basis of neurological disorders)
Electronic Video -
5
Update on fluid biomarkers for neurodegenerative diseases
Published 2022Table of Contents: “…Contents: Fluid biomarker candidates for neurodegenerative disease -- Amyloid pathology -- CSF and plasma/serum NfL -- CSF Aβ42 in Alzheimer's disease and neuroinflammatory diseases -- Tau pathology in Alzheimer's disease -- Neurodegeneration -- CSF and plasma NfL as biomarkers for disease progression -- Drug treatment and NfL levels.…”
Get full text
Series (Biomarkers)
Series (Drug discovery and development in the neurosciences)
Series (Genetic basis of neurological disorders)
Electronic Video -
6
Frontotemporal dementia
Published 2010Table of Contents: “…Contents: Prevalence and nomenclature of FTD -- The pathology of FTD (tau, TDP-43) -- The genetics of FTD (tau, progranulin) -- Patterns of atrophy and neuroanatomical correlates of behavior and cognition -- von Economo neurons -- Neuroimaging (amyloid imaging) -- Treatment.…”
Get full text
Series
Electronic Video -
7
Frontotemporal dementia
Published 2010Table of Contents: “…Contents: Prevalence and nomenclature of FTD -- The pathology of FTD (tau, TDP-43) -- The genetics of FTD (tau, progranulin) -- Patterns of atrophy and neuroanatomical correlates of behavior and cognition -- von Economo neurons -- Neuroimaging (amyloid imaging) -- Treatment.…”
Get full text
Series
Electronic Video -
8
A molecular understanding of Alzheimer's disease
Published 2021Table of Contents: “…Contents: Usefulness of genetics in understanding AD -- Pathology of diseases -- Amyloid protein -- Genetic maps -- Mechanism of late onset Alzheimer's -- Role of presenilin in amyloid pathology -- Tau and frontotemporal dementia -- Tau splice site mutations -- Pathways to neurodegeneration.…”
Get full text
Series
Electronic Video -
9
A molecular understanding of Alzheimer's disease
Published 2021Table of Contents: “…Contents: Usefulness of genetics in understanding AD -- Pathology of diseases -- Amyloid protein -- Genetic maps -- Mechanism of late onset Alzheimer's -- Role of presenilin in amyloid pathology -- Tau and frontotemporal dementia -- Tau splice site mutations -- Pathways to neurodegeneration.…”
Get full text
Series
Electronic Video -
10
Neurodegenerative disease expression levels of normal sequence pathogenic proteins contribute to risk of disease /
Published 2021Subjects: Get full text
Series
Electronic Video -
11
Neurodegenerative disease expression levels of normal sequence pathogenic proteins contribute to risk of disease /
Published 2021Subjects: Get full text
Series
Electronic Video -
12
Roles for Hsp40 molecular chaperones in protein misfolding disease
Published 2012Table of Contents: “…Contents: Protein aggregation in conformational disease -- The Hsp40 system -- The Hsp70 system -- Small oligomers, prion, yeast, Huntington's disease and protein triage -- Mechanisms for proteotoxicity -- Mechanisms for amyloid disease.…”
Get full text
Series
Electronic Video -
13
Roles for Hsp40 molecular chaperones in protein misfolding disease
Published 2012Table of Contents: “…Contents: Protein aggregation in conformational disease -- The Hsp40 system -- The Hsp70 system -- Small oligomers, prion, yeast, Huntington's disease and protein triage -- Mechanisms for proteotoxicity -- Mechanisms for amyloid disease.…”
Get full text
Series
Electronic Video -
14
Roles for Hsp40 molecular chaperones in protein misfolding disease
Published 2012Table of Contents: “…Contents: Protein aggregation in conformational disease -- The Hsp40 system -- The Hsp70 system -- Small oligomers, prion, yeast, Huntington's disease and protein triage -- Mechanisms for proteotoxicity -- Mechanisms for amyloid disease.…”
Get full text
Series
Electronic Video -
15
Molecular brain imaging (PET) in diseases with dementia
Published 2020Table of Contents: “…Contents: Brain imaging with positron emission tomography (PET) for dementia diagnosis and research -- Cerebral glucose metabolism in mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia & depression -- Imaging of pathological markers (beta-amyloid and tau) in Alzheimer's disease -- Imaging of neurotransmitters and receptors, in the dopaminergic and cholinergic system -- Multiple systems profiling in dementia, Parkinson's and related motor disorders.…”
Get full text
Series (Periodic reports)
Series (Neurodegenerative diseases)
Electronic Video -
16
Molecular brain imaging (PET) in diseases with dementia
Published 2020Table of Contents: “…Contents: Brain imaging with positron emission tomography (PET) for dementia diagnosis and research -- Cerebral glucose metabolism in mild cognitive impairment, Alzheimer's disease, dementia with Lewy bodies, frontotemporal dementia & depression -- Imaging of pathological markers (beta-amyloid and tau) in Alzheimer's disease -- Imaging of neurotransmitters and receptors, in the dopaminergic and cholinergic system -- Multiple systems profiling in dementia, Parkinson's and related motor disorders.…”
Get full text
Series (Periodic reports)
Series (Neurodegenerative diseases)
Electronic Video -
17
Metabolic syndrome and neurological disorders /
Published 2013Table of Contents: “…Farooqui & Tahira Farooqui -- Lipids, cholesterol and oxidized cholesterol in Alzheimer's Amyloid Beta-mediated neurotoxicity / Mun'delanji Vestergaard, Masamune Morita, Tsutomu Hamada & Masahiro Takagi -- Of sound mind and body : dietary lifestyles, promotion of healthy brain aging and prevention of dementia in healthy individuals / Giulio Maria Pasinetti, Amanda Bilski, Lap Ho, Jun Wang, Mario Ferruzzi, Masahito Yamada, Kenjiro Ono & Salvatore Mannino -- Metabolic syndrome as an independent risk factor of silent brain infarction / Jae-Sung Lim & Hyung-Min Kwon -- Neurochemical linkage among metabolic syndrome, Alzheimer's disease, and depression / Undurti N. …”
An electronic book accessible through the World Wide Web; click to view
Electronic eBook